Clovis Oncology Inc Ret. on equity
What is the Ret. on equity of Clovis Oncology Inc?
The Ret. on equity of Clovis Oncology Inc is 73.67%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Clovis Oncology Inc
Companies with ret. on equity similar to Clovis Oncology Inc
- Vulcan Steel Ltd has Ret. on equity of 73.06%
- Artisan Partners Asset Management Inc has Ret. on equity of 73.24%
- Novo Nordisk A/S has Ret. on equity of 73.26%
- Novo Nordisk has Ret. on equity of 73.26%
- Novo Nordisk A/S has Ret. on equity of 73.26%
- China Billion Resources has Ret. on equity of 73.42%
- Clovis Oncology Inc has Ret. on equity of 73.67%
- Bioventix Plc has Ret. on equity of 73.73%
- Griffon has Ret. on equity of 73.83%
- RockRose PLC has Ret. on equity of 73.96%
- HiTech Australia has Ret. on equity of 74.06%
- Lam Research has Ret. on equity of 74.09%
- Artificial Solutions International AB (publ) has Ret. on equity of 74.11%